ConvaTec Group

ConvaTec Group EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ConvaTec Group (CTEC.L) as of Nov 18, 2026 is 459.54 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 370.50 M USD — a change of 24.03% (higher).

EBITDA

459.54 MUSD

YoY

24.03%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ConvaTec Group is 2025 459.54 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ConvaTec Group was 2024 370.50 M USD. It decreases by 24.03% higher compared to the previous year.

The ConvaTec Group EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
308.20 M USD
Jan 1, 2019
243.70 M USD
Jan 1, 2020
241.00 M USD
Jan 1, 2021
240.10 M USD
Jan 1, 2022
241.60 M USD
Jan 1, 2023
304.90 M USD
Jan 1, 2024
370.50 M USD
Jan 1, 2025
459.54 M USD
The ConvaTec Group EBITDA history
YEAREBITDAYoY
459.54 MUSD+24.03%
370.50 MUSD+21.52%
304.90 MUSD+26.20%
241.60 MUSD+0.62%
240.10 MUSD-0.37%
241.00 MUSD-1.11%
243.70 MUSD-20.93%
308.20 MUSD+1.88%
302.50 MUSD+35.83%
222.70 MUSD-19.02%
275.00 MUSD-14.17%
320.40 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ConvaTec Group Stock analysis

What does ConvaTec Group do? ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. The company was founded in the UK in 1978 and has since established a strong presence in over 100 markets worldwide. Over time, ConvaTec has become a significant leader in the healthcare industry. The company was originally founded by doctors to develop better therapies for patients with chronic diseases and wounds. It started with the development of skincare products for individuals with impaired skin barrier, such as patients with stoma and incontinence. Today, ConvaTec offers a variety of products and therapies for chronic diseases and wounds. ConvaTec operates its business in multiple product segments, each offering unique products and services. These segments include Advanced Wound Care, Infusion Devices, Stoma Care, and Continence and Critical Care. As a company, ConvaTec places a strong emphasis on innovation and research to continuously improve products and meet new medical needs. Collaborating closely with physicians, nursing staff, and patients is also emphasized. ConvaTec offers a comprehensive product portfolio. Advanced Wound Care includes a wide range of wound care products, including hydrocolloid dressings, foam dressings, and other biological collagen products. Infusion Devices consist of pump systems and catheters for administering fluids, medications, and nutrients over an extended period. Stoma Care produces products that support patients with an artificial opening to continue their daily lives as normally as possible. Continence and Critical Care provide solutions for bladder and bowel management of patients in critical situations, such as intensive care units. ConvaTec has become a leading company in the field of medical products and technologies over the years, thanks to its innovative products and a consistent focus on meeting people's needs. Through the use of new technologies and a strong focus on user feedback, ConvaTec has contributed to improving the lives of patients worldwide. Output: ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. ConvaTec Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ConvaTec Group stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ConvaTec Group is 459.54 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ConvaTec Group changed from 370.50 M USD to 459.54 M USD, representing a 24.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) ConvaTec Group since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ConvaTec Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ConvaTec Group

All Key Metrics — ConvaTec Group